
Ep. 10 - The Link Between Obesity and Chronic Disease: A Deeper Dive into SGLT2 Inhibitors
05/27/24 • 17 min
In this educational podcast, Dr. Walker discusses the latest research on a new class of diabetes drugs called SGLT2 inhibitors like Jardiance. He explains how these medications work by blocking glucose reabsorption in the kidneys, causing it to be excreted in urine. While initially developed and approved for diabetes, extensive clinical trials have shown SGLT2 inhibitors provide significant benefits for heart failure, kidney disease, and weight loss. Dr. Walker reviews the evidence demonstrating their ability to reduce mortality, heart failure episodes, and progression to end-stage kidney disease. He also discusses proper hygiene practices for patients experiencing sugar in the urine. If you want to learn more about how SGLT2 inhibitors are revolutionizing treatment of diabetes and related conditions, watch this informative discussion.
Keynotes: This educational podcast discusses how the diabetes medication class called SGLT2 inhibitors such as Jardiance work by blocking glucose reabsorption in the kidneys, causing it to be excreted in urine, and reviews the extensive evidence that they provide significant benefits for heart failure, kidney disease, weight loss, and reducing mortality.
Timestamps:
0:00-4:00 Introduction and how SGLT2 inhibitors work
4:00-8:00 Benefits for heart failure
8:00-12:00 Additional benefits and approvals for kidney disease and weight loss
12:00-14:00 Hygiene considerations and reducing kidney failure risk
14:00-End Q&A and conclusions
For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com
In this educational podcast, Dr. Walker discusses the latest research on a new class of diabetes drugs called SGLT2 inhibitors like Jardiance. He explains how these medications work by blocking glucose reabsorption in the kidneys, causing it to be excreted in urine. While initially developed and approved for diabetes, extensive clinical trials have shown SGLT2 inhibitors provide significant benefits for heart failure, kidney disease, and weight loss. Dr. Walker reviews the evidence demonstrating their ability to reduce mortality, heart failure episodes, and progression to end-stage kidney disease. He also discusses proper hygiene practices for patients experiencing sugar in the urine. If you want to learn more about how SGLT2 inhibitors are revolutionizing treatment of diabetes and related conditions, watch this informative discussion.
Keynotes: This educational podcast discusses how the diabetes medication class called SGLT2 inhibitors such as Jardiance work by blocking glucose reabsorption in the kidneys, causing it to be excreted in urine, and reviews the extensive evidence that they provide significant benefits for heart failure, kidney disease, weight loss, and reducing mortality.
Timestamps:
0:00-4:00 Introduction and how SGLT2 inhibitors work
4:00-8:00 Benefits for heart failure
8:00-12:00 Additional benefits and approvals for kidney disease and weight loss
12:00-14:00 Hygiene considerations and reducing kidney failure risk
14:00-End Q&A and conclusions
For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com
Previous Episode

Ep. 9 - The Obesity Epidemic and New Medication Options for Weight Loss
In this episode of the Cardiovascular Matters podcast, host Dr. Craig Walker discusses the growing problem of obesity in America and revolutionary new medication options that are helping people safely and effectively lose weight. Dr. Walker explains how obesity increases the risk of heart disease, diabetes and other serious health conditions. He then outlines several new classes of drugs, including GLP-1 agonists, that work to control hunger and blood sugar levels while promoting weight loss. Medical device sales veteran and patient Terry Roberts shares his own positive experience using these medications. Listeners will learn about treatment options and get insight into safely and successfully managing their weight.
Key points:
- The health risks of obesity like heart disease, diabetes and joint problems
- New classes of drugs for weight loss like GLP-1 agonists
- How the drugs work to control hunger, blood sugar and promote weight loss
- Positive results seen in weight loss and cardiovascular outcomes
- Terry Roberts shares his success with the medication plan
Chapter Markers:
0:00-5:00 - Introduction and overview of topic
5:00-10:00 - Health risks of obesity like heart disease and diabetes
10:00-15:00 - Introduction to new classes of weight loss drugs like GLP-1 agonists
15:00-20:00 - How the drugs work to control hunger and blood sugar
20:00-25:00 - Positive results seen in weight loss and cardiovascular outcomes
25:00-30:00 - Terry Roberts shares his success with the medication plan
30:00-35:00 - Q&A and call to action for listeners considering treatment
For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com
Next Episode

Ep. 11 - Men's health Preventative Screening Guide: Don't Wait for Symptoms!!
In this episode of Cardiovascular Matters, Dr. Craig Walker discusses the importance of regular preventative health screenings for men to assess risk factors and detect early signs of cardiovascular disease. He recommends basic blood tests to check cholesterol levels, inflammation markers, and overall health. Additional tests like calcium scoring of the heart arteries and treadmill stress tests can identify issues like plaque buildup and blocked vessels before symptoms appear.
Detecting problems early through screening allows lifestyle changes like diet, exercise and smoking cessation, as well as medications to lower cholesterol, blood pressure and inflammation. This prevents further disease progression and reduces the risk of future heart attacks and strokes. Dr. Walker shares stories of discovering severe but asymptomatic disease in young patients to emphasize the value of screening. He also outlines the different types of strokes and exams that can check for risks like blocked neck arteries. The podcast promotes the message that taking control of heart health through regular checkups and testing can add years to men's lives and keep them active.
Timestamps:
0:00-5:00 Introduction and family history importance
5:00-10:00 Recommended basic blood tests
10:00-13:00 Additional tests like calcium scoring
13:00-16:00 Types of strokes and how to check for risks
16:00-19:50 Importance of detecting peripheral artery disease
19:50-22:00 New medications that can help reverse disease
22:00-25:00 Story about discovering risk in young asymptomatic men
25:00-29:00 Importance of lifestyle changes plus medical treatment
29:00-32:00 Closing message on the value of preventative screening
For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/cardiovascular-matters-576274/ep-10-the-link-between-obesity-and-chronic-disease-a-deeper-dive-into-73316764"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to ep. 10 - the link between obesity and chronic disease: a deeper dive into sglt2 inhibitors on goodpods" style="width: 225px" /> </a>
Copy